Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

AdaptHealth (AHCO) Long-Term Debt Issuances (2018 - 2023)

AdaptHealth has reported Long-Term Debt Issuances over the past 5 years, most recently at $50.0 million for Q1 2023.

  • For Q1 2023, Long-Term Debt Issuances changed N/A year-over-year to $50.0 million; the TTM value through Dec 2023 reached $50.0 million, changed N/A, while the annual FY2024 figure was $253.5 million, 406.95% up from the prior year.
  • Long-Term Debt Issuances for Q1 2023 was $50.0 million at AdaptHealth, down from $600.0 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $600.0 million in Q3 2021 and troughed at -$219.5 million in Q3 2019.
  • A 4-year average of $200.0 million and a median of $159.8 million in 2019 define the central range for Long-Term Debt Issuances.
  • Biggest five-year swings in Long-Term Debt Issuances: surged 103751.87% in 2019 and later tumbled 30.0% in 2020.
  • Year by year, Long-Term Debt Issuances stood at -$219.5 million in 2019, then soared by 227.56% to $280.0 million in 2020, then surged by 114.29% to $600.0 million in 2021, then plummeted by 91.67% to $50.0 million in 2023.
  • Business Quant data shows Long-Term Debt Issuances for AHCO at $50.0 million in Q1 2023, $600.0 million in Q3 2021, and $500.0 million in Q1 2021.